• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

夫精宫腔内人工授精自然周期与促排卵周期妊娠结局的回顾性研究。

The pregnancy outcomes of intrauterine insemination with husband's sperm in natural cycles versus ovulation stimulated cycles: A retrospective study.

机构信息

Department of Reproductive Center, Zhoushan Maternity and Child Healthcare Hospital.

Laboratory for Reproductive Immunology, Hospital & Institute of Obstetrics and Gynecology, Shanghai Medical College, Fudan University.

出版信息

Biosci Trends. 2018;12(5):463-469. doi: 10.5582/bst.2018.01164.

DOI:10.5582/bst.2018.01164
PMID:30473553
Abstract

To compare the clinical outcomes of intrauterine insemination (IUI) with or without ovulation induction (OI), IUI cycles from January 2008 to December 2017 in Zhoushan Maternity and Child Healthcare Hospital were included, consisting of 455 natural cycles and 536 OI cycles. The overall clinical pregnancy rate did not differ between the two groups (P > 0.05). Stratified by OI medications such as clomiphene (CC), human menopausal gonadotropin (HMG) and follicle stimulating hormone (FSH), the pregnancy rates in HMG, CC, CC+HMG, and FSH/FSH+HMG groups were 11.70%, 13.58%, 15.95%, and 13.46%, respectively, but the difference was not significant compared with natural cycles (P > 0.05). Stratified by infertility etiology, the pregnancy rate was significantly higher in stimulated cycles than natural cycles with ovulation disorders (P < 0.01) and unexplained factors (P < 0.01) while it was significantly lower regarding cervical factors (P < 0.01), endometriosis (P < 0.05), male factor (P < 0.01) and other female factors. There was no strong difference of pregnancy rate for biparental causes (P > 0.05). Stratified by age category, women over 35 had higher pregnancy rate in stimulated cycles compared with natural cycles (18.75 vs. 12.24%; P < 0.05), while women under 35 had no significant difference of pregnancy rate between the two groups (13.65 vs 13.05%; P > 0.05). However, there was no significant difference between each ovarian stimulation group and natural cycle group regardless of the infertility causes or age categories. To conclude, IUI-OI could achieve a higher overall pregnancy rate for women over 35 and infertile patients with ovulation disorders and unexplained factors.

摘要

为了比较有或无排卵诱导(OI)的宫腔内人工授精(IUI)的临床结局,纳入了 2008 年 1 月至 2017 年 12 月在舟山妇幼保健院进行的 IUI 周期,包括 455 个自然周期和 536 个 OI 周期。两组的总临床妊娠率无差异(P>0.05)。按 OI 药物(如氯米芬(CC)、人绝经期促性腺激素(HMG)和卵泡刺激素(FSH))分层,HMG、CC、CC+HMG 和 FSH/FSH+HMG 组的妊娠率分别为 11.70%、13.58%、15.95%和 13.46%,但与自然周期相比差异无统计学意义(P>0.05)。按不孕病因分层,排卵障碍(P<0.01)和不明原因(P<0.01)的刺激周期妊娠率明显高于自然周期,而宫颈因素(P<0.01)、子宫内膜异位症(P<0.05)、男性因素(P<0.01)和其他女性因素的刺激周期妊娠率明显低于自然周期。对于双亲原因,妊娠率无明显差异(P>0.05)。按年龄分类,35 岁以上的女性刺激周期妊娠率高于自然周期(18.75%比 12.24%;P<0.05),而 35 岁以下的女性两组妊娠率无差异(13.65%比 13.05%;P>0.05)。然而,无论不孕病因或年龄分类如何,每个卵巢刺激组与自然周期组之间均无显著差异。综上所述,IUI-OI 可提高 35 岁以上女性和排卵障碍及不明原因不孕患者的总妊娠率。

相似文献

1
The pregnancy outcomes of intrauterine insemination with husband's sperm in natural cycles versus ovulation stimulated cycles: A retrospective study.夫精宫腔内人工授精自然周期与促排卵周期妊娠结局的回顾性研究。
Biosci Trends. 2018;12(5):463-469. doi: 10.5582/bst.2018.01164.
2
Low-dose human menopausal gonadotrophin versus clomiphene citrate in subfertile couples treated with intrauterine insemination: a randomized controlled trial.低剂量人绝经期促性腺激素与枸橼酸氯米酚在宫腔内人工授精治疗不孕夫妇中的应用:一项随机对照试验。
Hum Reprod. 2015 May;30(5):1079-88. doi: 10.1093/humrep/dev062. Epub 2015 Mar 18.
3
Management of ovulation induction and intrauterine insemination in infertile patients with hypogonadotropic hypogonadism.低促性腺激素性性腺功能减退不孕患者的促排卵及宫腔内人工授精管理
J Gynecol Obstet Hum Reprod. 2019 Dec;48(10):833-838. doi: 10.1016/j.jogoh.2019.03.027. Epub 2019 Mar 29.
4
The pregnancy rates with intrauterine insemination (IUI) in superovulated cycles employing different protocols (clomiphen citrate (CC), human menopausal gonadotropin (HMG) and HMG+CC) and in natural ovulatory cycle.在采用不同方案(枸橼酸氯米芬(CC)、人绝经期促性腺激素(HMG)以及HMG+CC)的超排卵周期和自然排卵周期中,经宫腔内人工授精(IUI)后的妊娠率。
J Pak Med Assoc. 2004 Oct;54(10):503-5.
5
Recombinant FSH increases live birth rates as compared to clomiphene citrate in intrauterine insemination cycles in couples with subfertility: a prospective randomized study.在不育夫妇的宫腔内人工授精周期中,与枸橼酸氯米芬相比,重组促卵泡激素可提高活产率:一项前瞻性随机研究。
Eur J Obstet Gynecol Reprod Biol. 2015 Jun;189:33-7. doi: 10.1016/j.ejogrb.2015.03.023. Epub 2015 Mar 28.
6
Effects of Letrozole-HMG and Clomiphene-HMG on Incidence of Luteinized Unruptured Follicle Syndrome in Infertile Women Undergoing Induction Ovulation and Intrauterine Insemination: A Randomised Trial.来曲唑-人绝经期促性腺激素与克罗米芬-人绝经期促性腺激素对接受诱导排卵和宫内人工授精的不孕女性黄素化未破裂卵泡综合征发生率的影响:一项随机试验
Glob J Health Sci. 2015 Sep 1;8(4):244-52. doi: 10.5539/gjhs.v8n4p244.
7
Ovarian stimulation in infertile women treated with the use of intrauterine insemination: a cohort study from China.宫腔内人工授精治疗不孕女性的卵巢刺激:来自中国的队列研究。
Fertil Steril. 2018 May;109(5):872-878. doi: 10.1016/j.fertnstert.2018.01.008.
8
Ovulation induction and intrauterine insemination in infertile women with polycystic ovary syndrome: A comparison of drugs.多囊卵巢综合征不孕女性的促排卵及宫腔内人工授精:药物比较
Eur J Obstet Gynecol Reprod Biol. 2018 Dec;231:117-121. doi: 10.1016/j.ejogrb.2018.08.002. Epub 2018 Aug 3.
9
Intrauterine insemination versus timed intercourse in ovulation induction cycles with clomiphene citrate for polycystic ovary syndrome: A retrospective cohort study.多囊卵巢综合征患者在克罗米芬柠檬酸盐促排卵周期中宫内授精与定时性交的比较:一项回顾性队列研究。
J Gynecol Obstet Hum Reprod. 2019 Dec;48(10):805-809. doi: 10.1016/j.jogoh.2019.07.002. Epub 2019 Jul 2.
10
Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.35岁及以上女性宫腔内人工授精周期中高纯度人绝经期促性腺激素与重组促卵泡激素加重组促黄体生成素的比较:一项随机对照试验
Hum Reprod. 2015 Jan;30(1):179-85. doi: 10.1093/humrep/deu302. Epub 2014 Nov 14.

引用本文的文献

1
Scoring prognostic factors for pregnancy post-intrauterine insemination in couples with infertility.宫内人工授精后不孕夫妇妊娠的预后因素评分
Pan Afr Med J. 2025 Mar 3;50:64. doi: 10.11604/pamj.2025.50.64.45962. eCollection 2025.
2
A comprehensive evaluation of pre- and post-processing sperm parameters for predicting successful pregnancy rate following intrauterine insemination with the husband's sperms.对预处理和后处理精子参数进行综合评估,以预测使用丈夫精子进行宫腔内人工授精后的成功妊娠率。
BMC Pregnancy Childbirth. 2022 Sep 12;22(1):703. doi: 10.1186/s12884-022-05029-8.
3
Evaluation of Prognostic Factors for Clinical Pregnancy Rate Following Artificial Insemination by Husband in the Chinese Population.
中国人群中丈夫精液人工授精后临床妊娠率的预后因素评估。
Front Med (Lausanne). 2021 May 10;8:638560. doi: 10.3389/fmed.2021.638560. eCollection 2021.
4
Oncofertility care in young women and the outcomes of pregnancy over the last 5 years.年轻女性的肿瘤生育护理及过去5年的妊娠结局。
Future Sci OA. 2021 Feb 2;7(4):FSO680. doi: 10.2144/fsoa-2020-0169.